Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin superfamily member 11 (IGSF11) is a cell-adhesion molecule belonging to the immunoglobulin superfamily, with high expression in the brain and testis. It mediates calcium-independent homophilic cell adhesion, regulates synaptic transmission and plasticity in neurons via interactions with PSD95, and maintains the blood-testis barrier for male fertility. IGSF11 is also quickly upregulated in osteoclast precursors, where it regulates osteoclast maturation and bone resorption through both cell-cell interaction and metabolic modulation (pyruvate kinase M2 activity). In immune cells, IGSF11 inhibits human T cell activation via its binding partner VSIG3. Aberrant expression is associated with diseases such as osteoarthritis and certain cancers, where it acts as a cancer/testis antigen and supports cancer cell growth.
No specific mechanism of action for drugs found in search results, but given its role as a cell adhesion molecule and immune regulator, possible mechanisms may include inhibition of cell-cell adhesion, blockade of immune checkpoint signaling, or modulation of osteoclast activity (inference based on biological function).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin superfamily member 11 (IGSF11).